8 Coupons
-
Special Offer
-
30% off
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid. .
one downside to existing drugs that prevent migraine is they can cause unpleasant side effects like
.
may 17, 2018
.
.
.